Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 30;5(12):e008636.
doi: 10.1136/bmjopen-2015-008636.

Starting antidepressant use: a qualitative synthesis of UK and Australian data

Affiliations

Starting antidepressant use: a qualitative synthesis of UK and Australian data

Claire Anderson et al. BMJ Open. .

Abstract

Objective: To explore people's experiences of starting antidepressant treatment.

Design: Qualitative interpretive approach combining thematic analysis with constant comparison. Relevant coding reports from the original studies (generated using NVivo) relating to initial experiences of antidepressants were explored in further detail, focusing on the ways in which participants discussed their experiences of taking or being prescribed an antidepressant for the first time.

Participants: 108 men and women aged 22-84 who had taken antidepressants for depression.

Setting: Respondents recruited throughout the UK during 2003-2004 and 2008 and 2012-2013 and in Australia during 2010-2011.

Results: People expressed a wide range of feelings about initiating antidepressant use. People's attitudes towards starting antidepressant use were shaped by stereotypes and stigmas related to perceived drug dependency and potentially extreme side effects. Anxieties were expressed about starting use, and about how long the antidepressant might begin to take effect, how much it might help or hinder them, and about what to expect in the initial weeks. People worried about the possibility of experiencing adverse effects and implications for their senses of self. Where people felt they had not been given sufficient time during their consultation information or support to take the medicines, the uncertainty could be particularly unsettling and impact on their ongoing views on and use of antidepressants as a viable treatment option.

Conclusions: Our paper is the first to explore in-depth patient existential concerns about start of antidepressant use using multicountry data. People need additional support when they make decisions about starting antidepressants. Health professionals can use our findings to better understand and explore with patients' their concerns before their patients start antidepressants. These insights are key to supporting patients, many of whom feel intimidated by the prospect of taking antidepressants, especially during the uncertain first few weeks of treatment.

Keywords: PRIMARY CARE; THERAPEUTICS.

PubMed Disclaimer

References

    1. Garfield S, Smith F, Francis SA. The paradoxical role of antidepressant medication—returning to normal functioning while losing the sense of being normal. J Ment Health 2003; 12:521–35. 10.1080/09638230310001603582 - DOI
    1. Dolovich L, Nair K, Sellors C et al. . Do patients’ expectations influence their use of medications? Can Fam Physician 2008;54:384–93. - PMC - PubMed
    1. Demyttenaere K, Albert A, Mesters P et al. . What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors? J Clin Psychiatry 2005;66:859–63. 10.4088/JCP.v66n0708 - DOI - PubMed
    1. van Geffen ECG, Hermsen JHCM, Heerdink ER et al. . The decision to continue or discontinue treatment: experiences and beliefs of users of selective serotonin-reuptake inhibitors in the initial months—a qualitative study. Res Social Adm Pharm 2011;7:134–50. 10.1016/j.sapharm.2010.04.001 - DOI - PubMed
    1. Byrne N, Regan C, Livingston G. Adherence to treatment in mood disorders. Curr Opin Psychiatry 2006;19:44–9. 10.1097/01.yco.0000191501.54034.7c - DOI - PubMed

Publication types

MeSH terms

Substances